<VariationArchive VariationID="549855" VariationName="NM_000546.6(TP53):c.1077del (p.Ser362fs)" VariationType="Deletion" Accession="VCV000549855" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-15" DateCreated="2018-08-20" MostRecentSubmission="2022-08-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="540580" VariationID="549855">
      <GeneList>
        <Gene Symbol="TP53" FullName="tumor protein p53" GeneID="7157" HGNC_ID="HGNC:11998" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7668421" stop="7687490" display_start="7668421" display_stop="7687490" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7571719" stop="7590867" display_start="7571719" display_stop="7590867" Strand="-" />
          </Location>
          <OMIM>191170</OMIM>
          <Haploinsufficiency last_evaluated="2021-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP53">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP53">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000546.6(TP53):c.1077del (p.Ser362fs)</Name>
      <CanonicalSPDI>NC_000017.11:7670631:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7670632" stop="7670632" display_start="7670632" display_stop="7670632" variantLength="1" positionVCF="7670631" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7573950" stop="7573950" display_start="7573950" display_stop="7573950" variantLength="1" positionVCF="7573949" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>S323fs</ProteinChange>
      <ProteinChange>S362fs</ProteinChange>
      <ProteinChange>S203fs</ProteinChange>
      <ProteinChange>S230fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7573950del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7573950del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7670632del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7670632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017013.2" sequenceAccession="NG_017013" sequenceVersion="2" change="g.21919del">
            <Expression>NG_017013.2:g.21919del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000546.6" sequenceAccession="NM_000546" sequenceVersion="6" change="c.1077del" MANESelect="true">
            <Expression>NM_000546.6:c.1077del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000537.3" sequenceAccession="NP_000537" sequenceVersion="3" change="p.Ser362fs">
            <Expression>NP_000537.3:p.Ser362fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126112.3" sequenceAccession="NM_001126112" sequenceVersion="3" change="c.1077del">
            <Expression>NM_001126112.3:c.1077del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119584.1" sequenceAccession="NP_001119584" sequenceVersion="1" change="p.Ser362fs">
            <Expression>NP_001119584.1:p.Ser362fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126113.3" sequenceAccession="NM_001126113" sequenceVersion="3" change="c.*96del">
            <Expression>NM_001126113.3:c.*96del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126114.3" sequenceAccession="NM_001126114" sequenceVersion="3" change="c.*184del">
            <Expression>NM_001126114.3:c.*184del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126115.2" sequenceAccession="NM_001126115" sequenceVersion="2" change="c.681del">
            <Expression>NM_001126115.2:c.681del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119587.1" sequenceAccession="NP_001119587" sequenceVersion="1" change="p.Ser230fs">
            <Expression>NP_001119587.1:p.Ser230fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126116.2" sequenceAccession="NM_001126116" sequenceVersion="2" change="c.*184del">
            <Expression>NM_001126116.2:c.*184del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126117.2" sequenceAccession="NM_001126117" sequenceVersion="2" change="c.*96del">
            <Expression>NM_001126117.2:c.*96del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126118.2" sequenceAccession="NM_001126118" sequenceVersion="2" change="c.960del">
            <Expression>NM_001126118.2:c.960del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119590.1" sequenceAccession="NP_001119590" sequenceVersion="1" change="p.Ser323fs">
            <Expression>NP_001119590.1:p.Ser323fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276695.3" sequenceAccession="NM_001276695" sequenceVersion="3" change="c.*96del">
            <Expression>NM_001276695.3:c.*96del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276696.3" sequenceAccession="NM_001276696" sequenceVersion="3" change="c.*184del">
            <Expression>NM_001276696.3:c.*184del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276697.3" sequenceAccession="NM_001276697" sequenceVersion="3" change="c.600del">
            <Expression>NM_001276697.3:c.600del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263626.1" sequenceAccession="NP_001263626" sequenceVersion="1" change="p.Ser203fs">
            <Expression>NP_001263626.1:p.Ser203fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276698.3" sequenceAccession="NM_001276698" sequenceVersion="3" change="c.*184del">
            <Expression>NM_001276698.3:c.*184del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276699.3" sequenceAccession="NM_001276699" sequenceVersion="3" change="c.*96del">
            <Expression>NM_001276699.3:c.*96del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276760.3" sequenceAccession="NM_001276760" sequenceVersion="3" change="c.960del">
            <Expression>NM_001276760.3:c.960del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263689.1" sequenceAccession="NP_001263689" sequenceVersion="1" change="p.Ser323fs">
            <Expression>NP_001263689.1:p.Ser323fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276761.3" sequenceAccession="NM_001276761" sequenceVersion="3" change="c.960del">
            <Expression>NM_001276761.3:c.960del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263690.1" sequenceAccession="NP_001263690" sequenceVersion="1" change="p.Ser323fs">
            <Expression>NP_001263690.1:p.Ser323fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_321" sequenceAccession="LRG_321">
            <Expression>LRG_321:g.21919del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126112.2" sequenceAccession="NM_001126112" sequenceVersion="2" change="c.1077delA">
            <Expression>NM_001126112.2:c.1077delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="191170.0044" DB="OMIM" />
        <XRef Type="rs" ID="1555524370" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000546.6(TP53):c.1077del (p.Ser362fs) AND Diamond-Blackfan anemia" Accession="RCV000677306" Version="2">
        <ClassifiedConditionList TraitSetID="1756">
          <ClassifiedCondition DB="MedGen" ID="C1260899">Diamond-Blackfan anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-05-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000546.6(TP53):c.1077del (p.Ser362fs) AND Bone marrow failure syndrome 5" Accession="RCV000714962" Version="5">
        <ClassifiedConditionList TraitSetID="45013">
          <ClassifiedCondition DB="MedGen" ID="C4748488">Bone marrow failure syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-08-20" MostRecentSubmission="2022-08-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30146126</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1756" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
                <XRef ID="88854002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blackfan Diamond syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anemia congenital erythroid hypoplastic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aregenerative anemia chronic congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Erythrogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Red cell aplasia, pure hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital hypoplastic anemia</ElementValue>
                <XRef ID="HP:0004810" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aase syndrome</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DBA</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDS</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6274" />
                <XRef ID="6274" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083626</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C1260899" DB="MedGen" />
              <XRef ID="D029503" DB="MeSH" />
              <XRef ID="MONDO:0015253" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004810" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005545" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="45013" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40763" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bone marrow failure syndrome 5</ElementValue>
                <XRef ID="MONDO:0032573" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BMFS5</ElementValue>
                <XRef Type="MIM" ID="618165" DB="OMIM" />
              </Symbol>
              <XRef ID="C4748488" DB="MedGen" />
              <XRef ID="MONDO:0032573" DB="MONDO" />
              <XRef Type="MIM" ID="618165" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1538689" SubmissionDate="2018-07-27" DateLastUpdated="2018-08-20" DateCreated="2018-08-20">
        <ClinVarSubmissionID localKey="TP53_1077" submittedAssembly="hg19" title="TP53_1077" />
        <ClinVarAccession Accession="SCV000786666" DateUpdated="2018-08-20" DateCreated="2018-08-20" Type="SCV" Version="1" SubmitterName="Department of Pediatrics, Hirosaki University Graduate School of Medicine" OrgID="506659" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous protein-truncating mutations in TP53 (c.1077delA, p.Ser362AlafsX8) was detected in a patient presented with congenital hypoplastic anemia, hypogammaglobulinemia, growth retardation, microcephally and mental retardation. The variant resulted in the loss of 32 residues from the C-terminal domain (CTD). Luciferase assay using the promoter of CDKN1A showed the p53 mutant had augmented transcriptional activities. When expressed in zebrafish and human-induced pluripotent stem cells, we observed impaired erythrocyte production. The patient shared several phenotypes with the knock-in mice expressing CTD-truncated p53, including bone marrow failure, microcephaly and severe growth retardation (Simeonova 2013, Hamard 2013). These findings demonstrate that the CTD-truncation mutations of TP53 cause a novel inherited bone marrow failure syndrome.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Sporadic</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>Japan</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>HiSeq 2000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2018-05-14" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003139" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000252" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0008850" />
              </Trait>
              <Comment>The individual had clinical phenotypes that partially mimicked DBA (e.g., pure red cell aplasia and growth retardation). Other features, such as hypogammaglobulinemia and microcephaly, are also seen in DBA, but more common in DC. His anemia did not respond to steroid therapy. He became transfusion-dependent and required a regular blood transfusion from early infancy. He needed regular IgG replacement therapy for persistent hypogammaglobulinemia. No cancers were identified in this individual.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP53">
              <Name>tumor protein p53</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001126112.2:c.1077delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0004810" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>TP53_1077</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1649096" SubmissionDate="2020-05-18" DateLastUpdated="2018-11-05" DateCreated="2018-11-05">
        <ClinVarSubmissionID localKey="191170.0044_BONE MARROW FAILURE SYNDROME 5" title="TP53, 1-BP DEL, 1077A_BONE MARROW FAILURE SYNDROME 5" />
        <ClinVarAccession Accession="SCV000845727" DateUpdated="2018-11-05" DateCreated="2018-11-05" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 5-year-old boy with bone marrow failure syndrome-5 (BMFS5; 618165), Toki et al. (2018) identified a de novo heterozygous 1-bp deletion (c.1077delA, NM_001126112.2) in exon 10 of the TP53 gene, predicted to result in a frameshift and premature termination (Ser362AlafsTer8). The mutation was found by whole-exome sequencing and confirmed by Sanger sequencing. In vitro functional expression studies showed that the TP53 mutant had increased transcriptional activity compared to controls. An unrelated patient with the disorder had a different mutation that resulted in the same truncated protein (see 191170.0043).</Attribute>
              <Citation>
                <ID Source="PubMed">30146126</ID>
              </Citation>
              <XRef DB="OMIM" ID="618165" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP53" />
          </GeneList>
          <Name>TP53, 1-BP DEL, 1077A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1077A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="191170.0044" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BONE MARROW FAILURE SYNDROME 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5007116" SubmissionDate="2022-08-09" DateLastUpdated="2022-08-15" DateCreated="2022-08-15">
        <ClinVarSubmissionID localKey="NM_000546.6:c.1077del|MedGen:C4748488" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002559214" DateUpdated="2022-08-15" DateCreated="2022-08-15" Type="SCV" Version="1" SubmitterName="Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille" OrgID="505759" OrganizationCategory="laboratory" OrgAbbreviation="CHRUL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000546.6:c.1077del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4748488" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11909744</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1538689" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008850" MappingRef="HP">
        <MedGen CUI="C1857641" Name="Severe postnatal growth retardation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1649096" TraitType="Disease" MappingType="Name" MappingValue="BONE MARROW FAILURE SYNDROME 5" MappingRef="Preferred">
        <MedGen CUI="C4748488" Name="Bone marrow failure syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1538689" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000252" MappingRef="HP">
        <MedGen CUI="C4551563" Name="Microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5007116" TraitType="Disease" MappingType="XRef" MappingValue="C4748488" MappingRef="MedGen">
        <MedGen CUI="C4748488" Name="Bone marrow failure syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1538689" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003139" MappingRef="HP">
        <MedGen CUI="C1328587" Name="Panhypogammaglobulinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1538689" TraitType="Disease" MappingType="XRef" MappingValue="HP:0004810" MappingRef="HP">
        <MedGen CUI="C1260899" Name="Diamond-Blackfan anemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>